| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
NeuBase Therapeutics Inc (NASDAQ: NBSE)
NBSE Technical Analysis
5
| As on 9th Jun 2023 NBSE STOCK Price closed @ 0.19 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.14 & Strong Sell for SHORT-TERM with Stoploss of 1.89 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NBSESTOCK Price
| Open | 0.19 | Change | Price | % |
| High | 0.19 | 1 Day | 0.00 | 0.00 |
| Low | 0.18 | 1 Week | 0.01 | 5.56 |
| Close | 0.19 | 1 Month | 0.06 | 46.15 |
| Volume | 46772 | 1 Year | -2.68 | -93.38 |
| 52 Week High 3.06 | 52 Week Low 0.13 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| NBSE Daily Charts |
NBSE Intraday Charts |
Whats New @ Bazaartrend |
NBSE Free Analysis |
|
|
NBSE Important Levels Intraday
| RESISTANCE | 0.21 |
| RESISTANCE | 0.20 |
| RESISTANCE | 0.20 |
| RESISTANCE | 0.20 |
| SUPPORT | 0.18 |
| SUPPORT | 0.18 |
| SUPPORT | 0.18 |
| SUPPORT | 0.17 |
NBSE Forecast May 2024
| 4th UP Forecast | 3.25 |
| 3rd UP Forecast | 2.27 |
| 2nd UP Forecast | 1.66 |
| 1st UP Forecast | 1.06 |
| 1st DOWN Forecast | -0.68 |
| 2nd DOWN Forecast | -1.28 |
| 3rd DOWN Forecast | -1.89 |
| 4th DOWN Forecast | -2.87 |
NBSE Weekly Forecast
| 4th UP Forecast | 1.38 |
| 3rd UP Forecast | 1.00 |
| 2nd UP Forecast | 0.76 |
| 1st UP Forecast | 0.53 |
| 1st DOWN Forecast | -0.15 |
| 2nd DOWN Forecast | -0.38 |
| 3rd DOWN Forecast | -0.62 |
| 4th DOWN Forecast | -1.00 |
NBSE Forecast2024
| 4th UP Forecast | 6.09 |
| 3rd UP Forecast | 4.2 |
| 2nd UP Forecast | 3.03 |
| 1st UP Forecast | 1.86 |
| 1st DOWN Forecast | -1.48 |
| 2nd DOWN Forecast | -2.65 |
| 3rd DOWN Forecast | -3.82 |
| 4th DOWN Forecast | -5.71 |
NeuBase Therapeutics Inc ( NASDAQ USA Symbol : NBSE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NBSE Business Profile
NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders and cancer. Its lead programs include NT0100, a PATrOL enabled anti-gene for Huntington's disease; and NT0200, a PATrOL enabled anti-gene for myotonic dystrophy type 1. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania. Address: 700 Technology Drive, Pittsburgh, PA, United States, 15219
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service